2011 ASH Program Book - American Society of Hypertension

More documents

Recommendations

Info

MAY 22 Plenary Session I Sunday Afternoon 1:15 PM – 3:00 PM • East Ballroom • Third Floor Plenary Session I Co-Chairs: George L. Bakris, MD, FASH, Chicago, IL and William B. White, MD, FASH, Farmington, CT 1:15 PM President’s Opening Address 1:30 PM Keynote Lecture: Blood Pressure in Obesity F. Xavier Pi‐Sunyer, MD, MPH, New York, NY 2:00 PM Cardiovascular Risk and Risk Reduction in Children and Adolescents Rae‐Ellen W. Kavey, MD, MPH, Rochester, NY 2:20 PM Mechanisms from Studies of Human Obesity Sadaf Farooqi, PhD, Cambridge, United Kingdom 2:40 PM Evaluation and Treatment of Hypertension in Childhood Joseph T. Flynn, MD, FASH, Seattle, WA 58
Sunday Afternoon MAY 22 Sessions 3:30 PM – 5:15 PM • Mercury Ballroom • Third Floor 1 Aldosterone Co-Chairs: J. Howard Pratt, MD, Indianapolis, IN and Gordon H. Williams, MD, Boston, MA 3:30 PM Non-Renal Effects of Aldosterone James M. Luther, MD, Nashville, TN 3:50 PM Interactions Between Aldosterone and Nitric Oxide Charles J. Lowenstein, MD, Rochester, NY 4:10 PM Role of Aldosterone and Mineralocorticoid Receptor Activation in Obesity Related Hypertension John E. Hall, PhD, Jackson, MS Original Communications 4:30 PM OR-6: Spironolactone Reverses Chlorthalidone- Induced Sympathetic Activation in Hypertensive Patients Prafull Raheja, Debbie Arbique, Zhijun Wang, Wanpen Vongpatanasin. UT Southwestern Medical Center, Dallas, TX, US. 4:45 PM OR-7: Plasma Aldosterone Levels Affect Calcium Metabolism in Patients with Essential Hypertension Gian Luca Colussi, Cristiana Catena, GianLuca Colussi, Leonardo A. Sechi. University of Udine, Udine, IT. 5:00 PM OR-8: Inappropriately Intense Salt Restriction, Which Causes Elevation of Plasma Aldosterone Level, Might Augment Myocardial Fibrosis in Animal Model of Renal Tubular Injury Tatsuhiko Mori, 1 Kenichi Hasegawa, 2 Hirohisa Matsuda, 1 Yasuo Matsumura, 2 Nobukazu Ishizaka. 1 1 Osaka Medical College, Takatsuki, JP; 2 Osaka University of Pharmaceutical Sciences, Takatsuki, JP. 1 Pathobiology Track 2 Translational Track 3 Therapy Track 59
Page 1 and 2:
American Society of Hypertension, I
Page 3:
Visit booth #1100 to find out more
Page 6 and 7:
Past Presidents of the American Soc
Page 8 and 9:
Program Color Key The pages of this
Page 10 and 11: Letter continued Following the Awar
Page 12 and 13: General Information continued Discl
Page 14 and 15: General Information continued ASH S
Page 16 and 17: General Information continued ASH P
Page 18 and 19: 2011 ASH Corporate Members Boehring
Page 20 and 21: ASH Leadership 2010-2011 Board of D
Page 22 and 23: Special Lecture Monday, May 23, 201
Page 24 and 25: Young Scholar Award* Monday, May 23
Page 26 and 27: Special Lecture Monday, May 23, 201
Page 28 and 29: 2011 Abstract Reviewers Lawrence J.
Page 30 and 31: More than half of hypertensive pati
Page 32 and 33: Poster Category Presentation Poster
Page 34 and 35: 2011 ASH Faculty Rajiv Agarwal, MD
Page 36 and 37: 2011 ASH Faculty continued David L.
Page 38 and 39: American Society of Hypertension, I
Page 40 and 41: Program Color Key The pages of this
Page 42 and 43: MAY 21 Saturday Morning Hypertensio
Page 44 and 45: MAY 21 Sessions Saturday Afternoon
Page 50 and 51: MAY 21 Posters Saturday Evening Pos
Page 52 and 53: MAY 22 Sunday morning Sessions cont
Page 54 and 55: MAY 22 Sessions Sunday Morning 9:00
Page 56 and 57: MAY 22 Sessions Sunday Morning 9:00
Page 58 and 59: MAY 22 Debates Sunday Morning 11:00
Page 62 and 63: MAY 22 Special Sessions Sunday Afte
Page 64 and 65: MAY 22 Sessions Sunday Afternoon 3:
Page 66 and 67: MAY 23 Satellite Symposium 6:00 AM
Page 68 and 69: MAY 23 Sessions Monday morning 8:00
Page 78 and 79: MAY 23 Plenary Session II Monday Af
Page 80 and 81: MAY 24 Sessions Tuesday Morning 8:1
Page 82 and 83: MAY 24 Sessions Tuesday Morning 10:
Page 84 and 85: MAY 24 Sessions Tuesday Morning 10:
Page 87 and 88: 2011 American Society of Hypertensi
Page 89 and 90: Saturday Afternoon MAY 21 Posters 4
Page 91 and 92: Saturday Afternoon MAY 21 Posters P
Page 93 and 94: Saturday Afternoon MAY 21 Posters E
Page 99 and 100: Saturday Afternoon MAY 21 Posters I
Page 107 and 108: Sunday Morning MAY 22 Posters 10:00
Page 109 and 110: Sunday Morning MAY 22 Posters 10:00
Page 111 and 112:
Sunday Morning MAY 22 Posters PO-13
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Monday Morning Afternoon MAY 21 23
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Faculty Disclosure Listing Rajiv Ag
Page 149 and 150:
Faculty Disclosure Listing continue
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
ASH Hypertension Resource Pavilion
Page 159 and 160:
2011 ASH Innovations Theater Rhinel
Page 161 and 162:
2011 ASH Exhibitors continued A & D
Page 163 and 164:
2011 ASH Exhibitors continued David
Page 165 and 166:
2011 ASH Exhibitors continued Inter
Page 167 and 168:
2011 ASH Exhibitors continued Novar
Page 169 and 170:
2011 ASH Exhibitors continued Wiley
Page 171 and 172:
Author Index Berezina, Aelita V., 8
Page 173 and 174:
Author Index Eguchi, Kazuo, 110, 13
Page 175 and 176:
Author Index Ikeda, Yasuhiro, 116 I
Page 177 and 178:
Author Index Makani, Harikrishna, 1
Page 179 and 180:
Author Index Rabelink, Ton J., 93 R
Page 181 and 182:
Author Index Tatsis, I., 92, 124 Ta
Page 183 and 184:
Hilton New York Floor Plans Second
Page 185 and 186:
Hilton New York Floor Plans Fourth
Page 187 and 188:
Tekamlo (aliskiren and amlodipine)
Page 189 and 190:
25% (systolic) and 27% (diastolic)
Page 191 and 192:
Two cases of angioedema with respir
Page 193 and 194:
amlodipine and sildenafil were used
Page 195 and 196:
Amlodipine besylate Single oral dos
show all

2011 ASH Program Book - American Society of Hypertension

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?